David R. Epstein - Aug 15, 2023 Form 4 Insider Report for Seagen Inc. (SGEN)

Role
Chief Executive Officer, Director
Signature
By: /s/ Jessica Nielsen Causey For: David R. Epstein
Stock symbol
SGEN
Transactions as of
Aug 15, 2023
Transactions value $
$0
Form type
4
Date filed
8/17/2023, 09:14 PM
Previous filing
Nov 10, 2022
Next filing
Nov 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Award $0 +39.7K +36.86% $0.00 147K Aug 15, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units and will be settled in common stock upon vesting. 50% of the reporting person's annual equity award was granted in the form of performance stock units, which are not reflected here, and will be treated the same as these restricted stock units in the event the transaction with Pfizer closes.
F2 Shares shall vest at a rate of 25% on each anniversary of August 15, 2023 until all shares are fully vested at the end of four years.
F3 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 179 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on July 31, 2023.